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Legumain is a dual-function protease–peptide ligase whose
activities are of great interest to researchers studying plant
physiology and to biotechnological applications. However, the
molecular mechanisms determining the specificities for prote-
olysis and ligation are unclear because structural information
on the substrate recognition by a fully activated plant legumain
is unavailable. Here, we present the X-ray structure of Arabi-
dopsis thaliana legumain isoform  (AtLEG) in complex with
the covalent peptidic Ac-YVAD chloromethyl ketone (CMK)
inhibitor targeting the catalytic cysteine. Mapping of the
specificity pockets preceding the substrate-cleavage site ex-
plained the known substrate preference. The comparison of
inhibited and free AtLEG structures disclosed a substrate-in-
duced disorder–order transition with synergistic rearrange-
ments in the substrate-recognition sites. Docking and in vitro
studies with an AtLEG ligase substrate, sunflower trypsin
inhibitor (SFTI), revealed a canonical, protease substrate–like
binding to the active site–bindingpockets preceding and follow-
ing the cleavage site. We found the interaction of the second
residue after the scissile bond, P2–S2, to be critical for decid-
ing on proteolysis versus cyclization. cis-trans-Isomerization of
the cyclic peptide product triggered its release from theAtLEG
active site and prevented inadvertent cleavage. The presented
integrative mechanisms of proteolysis and ligation (transpepti-
dation) explain the interdependence of legumain and its pre-
ferred substrates and provide a rational framework for engi-
neering optimized proteases, ligases, and substrates.
Over the last 20 years, plant legumains attracted increasing
attention largely due to their dual protease–peptide ligase func-
tion (1–4). Contrasting mammals, plants contain multiple
legumain isoforms (5, 6). Arabidopsis thaliana encodes four
legumain forms, two vegetative-type (AtLEG and ), one
seed-type (AtLEG), and a separate grouped (AtLEG). The
vegetative-type legumains, like AtLEG, are involved in plant-
programmed cell death (7, 8). This function is especially inter-
esting because plants lack caspases, which are homologous
to legumain and serve as key enzymes in mammalian-pro-
grammed cell death (9). Several studies showed that plant legu-
mains and caspases share the same substrates and inhibitors
due to their preference for acidic sequences such as Tyr-Val-
Ala-Asp, Val-Glu-Ile-Asp, and Ile-Glu-Thr-Asp (7, 10, 11).
Plant legumainmostly locate to the vacuoles and are, therefore,
alternatively referred to as vacuolar-processing enzymes (or
VPEs) (12). Legumains are synthesized as inactive precursors, or
zymogens, with a tripartite domain organization. It comprises an
N-terminal asparaginyl endopeptidase domain (AEP),2 an inter-
mediate activation peptide that blocks access to the active site
and thus confers enzymatic latency to the zymogen, and a
C-terminal legumain stabilization and activity modulation
(LSAM) domain, which renders legumain stable at neutral pH
and restricts substrate access to the active site (13).
Specific legumain isoforms differ strongly in their peptidase
and ligase activities toward certain substrates. For example, of
five tested legumains from Helianthus annus, A. thaliana iso-
form , Ricinus communis (castor bean), Canavalia ensiformis
(jack bean) legumain, and Clitoria ternatea (butelase-1), only
the latter two showed significant ligase activity, whereas the
others exhibited only proteolytic activity (14, 15). Recently, it
has been shown that AtLEG is able to efficiently ligate linear
peptides (16). Ligation was also reported for legumains from
another kingdom of life, in human and mouse legumain (3, 17,
18). Ligations are especially interestingwhenpeptides are head-
to-tail cyclized, thereby producing a large variety of cyclic pep-
tides. Examples are the potent sunflower trypsin inhibitor
(SFTI), one of the shortest cyclic peptides, and kalata B1, a
member of the so-called cyclotides (14, 15, 19). SFTI serves as
an ideal model peptide to study cyclization. Due to their special
structural properties such cyclic peptides play important roles
in plant defense strategies like pesticidial, insecticidal, antimi-
crobial, or nematodical activities (20–23). They all share com-
mon characteristics like a high thermal, pH, or proteolytic resis-
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In vivo, precursors of cyclic peptides, like PawS1 of SFTI (26),
are ribosomally synthesized and post-translationally modified,
e.g. by the formation of disulfide bridges or the removal of sig-
nal- or propeptides (27). During its maturation, pro-SFTI is
processed twice by legumain. Initially, legumain cleaves and
releases a flexible N-terminal propeptide from pro-SFTI (19,
27, 28). The subsequent cleavage and release of a C-terminal
propeptide is accompanied by a head-to-tail ligation, i.e. cycli-
zation, also catalyzed by legumain (19). However, not all pep-
tides are efficiently ligated/cyclized during the second pro-
cessing step by plant legumain (2, 15). Quite apparently, the
peptide sequence and structure determine its preference for
cleavage or cyclization/ligation with a strong preference for
hydrophobic residues in the so-called P2 position, which is the
second residue after the cleavage site (4, 14, 15, 29, 30). For a
definition of the nomenclature of the substrate recognition
sites according to Schechter and Berger, please see Ref. 31.
However, the specific role of this highly conserved residue
remained unclear.
Similarly, the detailed reaction mechanism underlying the
plant legumain-mediated ligation reaction remains contro-
versial. For several plant legumain isoforms, a thioester with
the catalytic cysteine was postulated as a critical reaction
intermediate (32). This so-called enzyme-acyl complex can
either be released by a water molecule (i.e. hydrolysis, classic
proteolytic cleavage) or by the nucleophile of an incoming N
terminus. In the latter case, a ligated (or cyclized) peptide
product is released from the legumain active site (1, 14, 19).
Remarkably, for human legumain ligation was reported to
occur at least partly independent of the catalytic cysteine.
Indeed, ligation was enhanced if the catalytic cysteine was
blocked, presumably by preventing re-hydrolysis of the
ligated peptide bond. Lacking the thioester activation, an
alternative activation by the proximal aspartimide (succin-
imide) was suggested (3, 17).
The incomplete atomistic understanding of mechanisms
and specificities for proteolysis and ligation by legumain also
reflects the lack of crystal structure information on the sub-
strate recognition by a fully activated plant legumain, i.e. the
catalytic AEP where the C-terminal activation peptide and
LSAM domain are released. Here, we report the crystal struc-
ture of the peptidase form (AEP) of AtLEG in covalent com-
plex with the substrate analogue Ac-YVAD chloromethyl
ketone (CMK). The structure maps the important substrate
recognition sites before and after the scissile peptide bond,
which are referred to as nonprimed and primed recognition
sites (31). Biochemical and computational analyses indicated
the importance of cis-trans-isomerization of the ligation
product as well as the shielding from the catalytic water
molecule.
Results
Overall structure
For a detailed understanding of how fully activated A. thali-
ana legumain  (AtLEG) recognizes a substrate, we solved the
crystal structure of the AtLEG peptidase (AEP) in complex
with the covalent peptidic CMK-based inhibitor Ac-YVAD-
CMK to 1.5-Å resolution (Fig. 1, Fig. S1). For statistics on data
collection and refinement see Table 1. The peptidase (AEP)
exhibited the characteristic six-stranded central -sheet (1–
6), which was surrounded by fivemajor and fiveminor -heli-
ces (Figs. S1 and S2) (13).
Delineating the substrate-recognition sites
Especially interesting were the substrate-recognition sites.
The nonprimed substrate recognition, i.e. the substrate binding
preceding the substrate’s scissile peptide bond, is facilitated by
the edge strands IV and V and a plant-specific insertion of 7
amino acids (aa) in the so-called c341 loop (13, 18) as compared
with human legumain (Fig. 1, Fig. S1 and S2; c341 and c381
referring to caspase 1 numbering (13)). The c381 specificity-
loop, which features a 7-aa insertion compared with mamma-
lian legumain (13) (Fig. S1), also significantly contributed to the
nonprimed substrate interaction. Assuming an extended bind-
ing mode of the peptide substrate, the primed sites C-terminal
to the scissile bond are located on the antiparallelI–III-sheet
(Fig. 1, Fig. S2).
Disorder–order transition upon zymogen activation
When we analyzed the AtLEG structure in complex with
theAc-YVAD-CMK ligandwe found the specificity loops (c341
and c381) and the edge strand (IV) highly ordered, contrasting
the zymogenic structure, displayed in relative B-factors, which
indicate the local flexibility (Fig. 2, a and b) (16). Although the
observed flexibility might be influenced by the packing within
the crystal lattice, the observed difference was corroborated by
two independentmolecules in the asymmetric unit for both the
active peptidase and the zymogenic structures, minimizing
potential influences by crystal lattice contacts (Fig. 2, a and b).
For Tyr307, the change was drastic and particularly functionally
relevant, because it defines the S4 substrate–binding site (Figs.
1 and 2).
Notably, the main chain interaction of the peptidic substrate
(Ac-YVAD-CMK) with the peptidase differed from that previ-
ously found for the activation peptide in the zymogenic struc-
ture (Fig. 2) (16). In the Ac-YVAD-CMK substrate analogue,
there were two major hydrogen bonds between the carbonyl
oxygen of Ser247 and amide nitrogen of Gly249 to P1 amide
nitrogen and P2 carbonyl oxygen, respectively. The P2 carbonyl
oxygen was further anchored by the side chain of Arg74. By
contrast, the activation peptide in the two-chain structure was
out of register and shifted for 2.5 Å to the N-terminal direction
(Fig. 2c). This observed shift is critical in rationalizing how the
activation peptide can confer enzymatic latency in the zymogen
structure: the out-of-register binding, albeit approximately
substrate-like, renders the activation peptide encounter com-
plex unproductive and prevents autocleavage of the activation
peptide. The out-of-register shift of the activation peptide as
compared with a productive peptide binding is mostly caused
by Gln354 rather than the classical Asn (or Asp) in the P1 posi-
tion, preceding the scissile peptide bond. The additional CH2
group in the Gln side chain displaces its main chain as well as
the neighboring P2 residue for 3.8 Å as compared with the
Ac-YVAD-CMK. Conversely, the lack of the canonical sub-
strate interactions resulted in the observed flexibility of the
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prominent c341 and c381 specificity loops in the zymogenic
structure, whereas these loops are highly ordered in the sub-
strate-bound state (Fig. 2, a and b).
Specificity pockets and active-site elements
The covalently bound Ac-YVAD-CMK substrate was clearly
visible in the electron density and allowed for an accurate
assignment of the nonprimed specificity pockets (Fig. 1, Fig.
S2b). The oxyanion hole was formed by the amide nitrogens of
Cys219 and Gly178 as well as of imidazole ring of His177 (N1)
(Fig. 1, Fig. S2b). Similarly as reported formammalian legumain
(13, 18), P1 Asp substrates are best accepted at pH 4.0 (3, 13,
33), where the P1 Asp is protonated within the S1-pocket. The
protonatedAspP1 carboxylate groupwas coordinated byAsp269
andGlu217 at the bottom, Ser247 on the upper side (“north”) and
Arg74 and His75 on the lower side (“south”) of the S1 pocket.
The P2 Ala interacted hydrophobically with Trp248. The P3 Val
was constrained by the Cys252–Cys266 disulfide bridge and the
guanidium group of Arg74. The P4 Tyr was surrounded by the
two prominent c341 and c381 specificity loops with their cen-
tral residues Tyr307 (c381) and the aliphatic part of Glu255
(c341). We could further identify a potential site for the cata-
lytic water in perfect position to attack a thioester intermediate.
The water was coordinated by the catalytic His177 in proximity
to the scissile carbonyl of AspP1 (Fig. S3, Fig. 6).
Cyclization of SFTI by AtLEG
To test whether AtLEG can cyclize a modified sunflower
trypsin inhibitor precursor peptide (SFTI-GL; 1GRCTRSIP-
PICFPDGL16), we monitored time-resolved ligation as cata-
lyzed by activated AtLEG. SFTI-GL was cyclized to C-SFTI
remarkably fast. Already after 1 min we detected 1/3 of the
precursor (SFTI-GL) being cyclized (C-SFTI) (Fig. 3). After 20
min, conversion of SFTI to its cyclic form was complete, with
10% each resulting in the linear form (L-SFTI) or not being
processed at all (precursor SFTI-GL). This distribution and the
absolute amounts remained constant for the tested time inter-
val of 12 h, implying and reflecting the proteolytic resistance of
cyclic SFTI (Fig. 3). We observed cyclization only in the pres-
ence of AtLEG and if the precursor SFTI carried the primed
residues (i.e. the C-terminal Gly15–Leu16), which were cleaved
off by AtLEG (Fig. 3, c and d). Interestingly, we did not find a
significant preference for oxidized or reduced SFTI-GL, in
agreement with previous reports (15).
Docking of SFTI reveals a canonical substrate-bindingmode
To understand how the precursor of SFTI is recognized by
AtLEG, we performed docking studies guided by the present
AtLEG-substrate complex structure. The nonprimed sub-
strate-binding sites (S4 to S1) of AtLEG served as receptor
sites and Asp14 of SFTI as the P1 ligand residue (cf. Fig. 1). The
Figure 1. Interaction topology of the peptidic Ac-YVAD-CMK inhibitor with fully activated AtLEG (AEP). The active form of AtLEG is displayed in
standard orientation, i.e. with substrate running from left to right. The specificity loops c341 and c381 are colored in blue or orange, respectively. a, complex
structure of the covalently boundAc-YVAD-CMK-based inhibitor in a cartoonmodel. b, surface representation of a showing how the specificity loops embrace
the substrate. c, mapping of the substrate recognition sites. The ligand and its electron density (2Fo Fc map, 1 contouring) are shown in blue. The pockets
and its main interactors are indicated with color code: black, S1; green, S2; blue, S3; orange, S4. The backbone interactions are shown in dashed lines.
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docking hits with the lowest free energy of binding were in
agreement with a canonical binding and resembled the experi-
mentally determined substrate-binding mode (Figs. 1 and 4).
Specifically, we found the carbonyl of P1 Asp14 to be docked
into the oxyanion hole (formed by the amides of Cys219 and
Gly178 as well as by His177) and further backbone interactions
such as the amide of Asp14(SFTI) with the carbonyl oxygen of
Ser247 and the carbonyl oxygen of Phe12(SFTI) with the amide
of Gly249, all consistent with the experimentally determined
substrate-bindingmode (Fig. 1). Furthermore, Pro13(SFTI) and
Phe12(SFTI) bound to the S2 and S3 pockets, respectively. Due
to the intramolecular disulfide of Cys11(SFTI) with Cys3(SFTI),
Ile10(SFTI) occupied the S4 pocket, interacting with Trp248.
Interestingly, the docking programpositioned the freeN termi-
nus of Gly1(SFTI) to form an ionic interactionwithGlu220 close
to the catalytic cysteine Cys219.
Proline 13(SFTI) switch allows canonical binding of linear
substrate and release of the cyclic product
Careful inspection of the docked structures revealed a major
difference of the docked linear SFTI to a cyclic SFTI at
Pro13(SFTI), which was 180° switched (cis-trans isomerized)
around the Phe12–Pro13 peptide bond (Fig. S4). This conforma-
tional isomerization might be triggered either: 1) by “pulling”
Phe12(SFTI) to the canonical S3 backbone interaction or 2) by
“pushing” SFTI away from AtLEG to avoid steric clashes with
AtLEG; or a combination of both.
Importantly, and contrasting the cyclic SFTI structure (21),
the ensemble of NMR solution structures (PDB entry 2AB9)
revealed Pro13(SFTI) as a wide spectrum of conformations in
the SFTI precursor, as did the C-terminal extension, which is
cleaved off before cyclization by legumain (2, 14, 28) (Fig. S5).
Accordingly, cyclization of SFTI is accompanied by the selec-
tion of a Pro13(SFTI) conformation (21), which is unfavorable
for binding to AtLEG. To further substantiate this conclusion,
we computationally enforced Pro13(SFTI) within the cyclic
SFTI to canonically interact with the S2 site, thereby also
inducing proper interaction of Asp14(SFTI) with the S1
pocket and the oxyanion hole. However, upon releasing
these restraints, Pro13(SFTI) switched back and pulled the
Asp14 carbonyl out of oxyanion hole. By contrast, the linear
SFTI peptide remained canonically bound also in the
absence of such restraints.
Bindingmodel of primed product residues and their role in
ligation
We next asked how primed residues C-terminal to the scis-
sile peptide bond would bind to AtLEG, and to which extent
they can prevent the catalytic water from premature hydrolysis
of the thioester bond. Thereby, we focused on the P1–S1 and
P2–S2 interactions, because these are reported to be espe-
Table 1
Statistics for AtLEG-CD in covalent complex with Ac-YVAD-CMK
AtLEG in covalent complex
with Ac-YVAD-CMK
Data collection
Space group P1211
Cell dimensions
a, b, c (Å) 41.74, 78.07, 77.72
, ,  (°) 90, 92.89, 90
Resolution (Å) 24.56 (1.5)
Rmerge 0.05 (0.24)
Rmeas 0.07 (0.34)
Rpim 0.05 (0.24)
Total number of observations 161,913 (7,215)
Total number unique 74,201 (3,597)
Completeness 93.5 (91.7)
Multiplicity 2.2 (2.0)
I/ 8.3 (2.7)
CC1/2 0.99 (0.78)
Wilson B-factor (Å2) 10.9
Refinement
Resolution (Å) 24.5–1.50
No. reflections 74,167
Rfree/Rwork 0.181/0.151
No. atoms 5,178
Protein 4,486
Ligand/ion 22
Water 670
B-factors 16.2
Protein 14.5
Ligand/ion 11.6
Water 27.9
Root mean square deviations
Bond lengths (Å) 0.006
Bond angles (°) 1.133
Clashcore 1.37
Ramachandran outlier (%) 0.00
Rotamer outlier (%) 0.41
Figure 2. Substrate recognition in the fully activated AtLEG (AEP) form
differs from the activation peptide (AP) binding in the zymogenic two-
chain statewith respect toboth structure anddynamics. Surface (left) and
cartoon representations are used to color code the conformational variabili-
ties by their crystallographic temperature factors. The color spectrum from
blue to red represents low to high conformational variability, i.e. rigid (blue) to
flexible (red). a, note the high temperature factors and multiple conforma-
tions of the specificity loops c341 and c381 in the zymogenic two-chain state.
b, the fully activated catalytic domain showswell-ordered specificity loops. c,
structural superposition of the activation peptide of the zymogenic two-
chain state (AP) in orange and the substrate Ac-YVAD in blue. Note the shift in
register of around 2.5 Å at the P1 C positions.
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cially important for ligation (2, 4, 15, 34) and, due to the known
constraint of the P1–S1 interaction, can be reliably extrapo-
lated. For stereochemical reasons the P1 residuemust have the
side chain exposed near the catalytic cysteine Cys219 and
Glu220, which delineate the S1 pocket. We further found a
remarkably pronounced S2 pocket in AtLEG, which is bor-
dered by Val182 (human Leg-Ile153; h-Ile153), Tyr192 (h-His162),
Tyr190 (h-Asp159), and Gly184 (h-Val155), with Gly184 forming
the bottom of the S2 pocket (Fig. 5). The deep S2 pocket
resulted, among others, from a conserved, plant-specific inser-
Figure 3. AtLEG efficiently cyclizes SFTI-GL but not cleaved SFTI. a, basic experiment design at pH 6.5. b, time course cyclization of SFTI-GL (reduced and
oxidized) byAtLEG and control experiments. No cyclic SFTIwas observedwhen the SFTI-GLwas incubatedwithout AtLEG. cor d,when L-SFTIwas incubated
with AtLEG.
Figure 4. Docking reveals canonical binding mode of SFTI. a, top view on the docked complex. b, interaction map of docked SFTI. Gray lines indicate
backbone interactions.
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tion at position 190 (Tyr190 in AtLEG or butelase-1; Fig. S1).
Furthermore, the S2 pocket is deepened by the basement res-
idue Gly184 as compared with the more bulky Val150 in human
legumain (Fig. 5, Fig. S1). To explore the binding mode of a
dipeptide at the S1 and S2 sites, we modeled a C-terminal
extension of the docked SFTI to obtain initial positions of the
P1 and P2 residues.
To further study the ligation/transpeptidation, we assumed a
thioester intermediate between the catalytic cysteine and the
P1 residue. Using molecular dynamics studies we tested the
retention time of the cleaved dipeptides (i.e. P1–P2) for
sequences that have been reported in efficient ligation/cycliza-
tion substrates, e.g. Gly15–Leu16(SFTI) or His15–Val16(SFTI)
(15). Remarkably, these two dipeptides remained bound within
the pocket even after 330-ns molecular dynamics simulation
and displaced the putative catalytic water (Fig. 6). By contrast,
dipeptides likeGly15–Gly16(SFTI) orGly15–Ser16(SFTI) rapidly
drifted out of the S1–S2 pockets during molecular dynamics
simulations, with retention times 30 ns. Subsequently, the
catalytic water entered the active site nearby His177, ready to
hydrolyze of the thioester bond (Fig. 6). The dipeptides Gly15–
Ala16(SFTI), Gly15–Val16(SFTI), or Glu15–Val16(SFTI) com-
peted with water for 100–150 ns, consistent with the
intermediate hydrophobicity of Gly15–Ala16(SFTI) or Gly15–
Val16(SFTI); the negative charge of Glu15 is disfavored as P1
residue due to its proximity to Glu220, which is partially bal-
anced by the hydrophobic P2 Val16 (Fig. 6).
Discussion
The bindingmode of the activation peptide in the zymogen
and a substrate differ markedly
In this study we solved the crystal structure of AtLEG in
complex with Ac-YVAD-CMK (Fig. 1, Figs. S1 and S2). In this
structure the binding mode of the peptidic substrate to the
active site markedly differed from that seen for the activation
peptide in the zymogen form (Fig. 2). Although the P1Gln354 of
the activation peptide mimics a P1 asparagine in the substrate,
it induced a partial frameshift of 2.5 Å in the activation
peptide backbone. This shift leads to distorted backbone–
backbone interactions and translates into more disordered
specificity loops (c341, c381; Fig. 1, Fig. S2). By contrast, the
canonical binding triggered an ordering of the S3–S4 pockets,
resulting in a tight binding of the P3 and P4 residues.
Structure-derived AtLEG specificity profile
The covalently bound Ac-YVAD-CMK allowed to deduce
the specificity of the nonprimed recognition sites (Fig. 1). The
S1 pocket is bipolar and sterically matches with Asp and Asn,
thus explaining its strong preference for Asn and protonated
Asp at P1. The open S2 pocket with its hydrophobic basement
(Trp248) explains the preference for hydrophobic residues. The
preference for mixed hydrophobic and partially negative P3
residues is consistent with Arg74 and the redox-sensitive disul-
fide bridge Cys252–Cys266 of the S3 pocket. The S4 site is very
adaptive, reflecting the conformational variability of the speci-
ficity conferring c341 and c381 loops (Fig. 2). These structure-
derived specificity predictions are in agreement with experi-
mentally determined specificities. For example, the caspase-1
(YVAD) inhibitor was reactive toward AtLEG, whereas the
caspase-3 inhibitor (DEVD) was not (8, 35). This observation is
in agreement with the negatively charged S4 pocket, which
should exclude a negatively charged P4 residue. Similarly,
the reported autocleavage sites of AtLEG, i.e. 340ADAN or
350RVTN, match the structure-derived specificity profile (16).
SFTI-bindingmodemimics the bindingmode of the6 helix in
the two-chain form of AtLEG
Docking of the SFTI inhibitor to the active site positioned its
N terminus Gly1(SFTI) next to Glu220, close to the catalytic
cysteine (Fig. 4). This stand-by position enables a coordinated
displacement of the primed SFTI (product) residues Gly15–
Leu16(SFTI).
We have previously shown that AtLEG can be activated to a
pH-stable intermediate (16). This two-chain form is a nonco-
valent complex of the catalytic domain and the C-terminal
domain comprising the 6 helix and LSAM (legumain stabili-
zation and activity modulation) module. Thereby, the 6-helix
was shown to act as critical gatekeeper for ligation substrates,
which was proposed to be specifically unlocked by a suitable
ligation substrate, whereas preventing premature proteolysis.
The N terminus of SFTI exactly coincides with the ionic
anchorage site of the 6-helix, i.e. Arg355 binding with Glu220.
Thus, SFTI mimics the interaction seen in the 6-helix (Fig.
S6). Indeed, we could detect significant cyclization of SFTI-GL
by the two-chain form, further supporting the correctness of
our docking model (Fig. S6).
Figure 5. S2 pockets for different legumain isoforms and position of the catalytic water.Different legumain isoforms are displayed in surface represen-
tation. Bright and dark green are the wall- and bottom-forming residues of the different legumain S2 pockets, respectively. A red sphere indicates the position
of the catalyticwater. The PDB IDof human legumain (hLEG) is 4AWA. The structure of AtLEGhas beenbuilt as an homologymodel usingAtLEG as a starting
model. The homology model of the catalytic domain of AtLEGwas built using the software Phyre2 (54).
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Primed side interaction favors cyclization by preventing
pre-mature thioester hydrolysis
Although several reports indicated an essential role of the P1
and P2 residues in ligation (4, 14, 15, 29, 30), their mechanistic
relevance remained so far unclear. Our analysis identified a
prominent hydrophobic S2 pocket, specific to plants. Efficient
ligases such as jack bean legumain, butelase-1, and AtLEG all
share an aromatic residue (Tyr or Phe) at position 190 and a
glycine at position 184 (Fig. 5, Fig. S1) (14, 15, 36).
Our computational studies showed that the catalytic water
could be displaced by the presence of the P1–P2 dipeptide
binding, in a sequence-dependent manner (Fig. 6). Hydro-
phobic P2 residues had longer retention times, correlating
with experimentally observed preferences in ligation sub-
strates (15).
We should note, however, that a recent publication by Yang
and colleagues (37) proposed the primed nucleophilic ligation
substrate employs a nonprimed binding site, i.e. it binds to the
left side rather to the right side as shown in Fig. 6. This conclu-
sion was presumably motivated by the C247A mutant, which
strongly enhanced ligase activity. However, this proposition is
sterically conflicting with the binding of the nonprimed ligase
substrate (Figs. 1a and 2, Fig. S2b).
To test our catalytic water displacement model, we com-
pared the cyclization efficacy between AtLEG and AtLEG.
The latter has Tyr190 (in AtLEG) substituted to histidine, thus
rendering the S2 pocket less hydrophobic. Indeed we detected
a significant higher portion of cleaved SFTI (linear SFTI) than
cyclic (Fig. S7), consistent with earlier reports (14). Conversely,
AtLEG may be a superior ligase over AtLEG for substrates
with P2 residues optimized for AtLEG’s amphiphilic S2 site.
These findings are in perfect agreement with a computational
report on human legumain-mediated transpeptidation, which
was only possible if waterwas excluded from the active site (38).
Finally we note that the proposed water displacement model is
consistent with the reportedly low proteolytic activity of bute-
lase (15) as well as the here observed 5000-fold decreased
proteolytic activity of AtLEG as compared with human legu-
main (Fig. S8).
Model of cyclization
Based on our findings, we hypothesize the cyclization of SFTI
is performed as illustrated in Fig. 7. Craik and colleagues (2, 14)
proposed that pro-SFTI is cleaved and ligated sequentially,
whereby the N-terminal segment of pro-SFTI is initially released
because of a kinetically preferred asparagine (Asn1(SFTI))
cleavage site (Fig. S5) (14, 28). In a second step, theN terminally
trimmed SFTI binds canonically with Asp14(SFTI) into the
active site, primarily exploiting the S4 to S2 sites, as we
observed in our docking studies (Figs. 4 and 6). The catalytic
cysteine can then form the acyl-enzyme intermediate, which is
long-lived due to the above described water displacement
model (Figs. 6 and 7). Subsequently, we propose the nucleo-
philic Gly1(SFTI) to bind to the S1 site, thereby displacing the
primed product residues (2), followed by aminolysis of the thio-
ester resulting in the cyclic peptide.
A possible reaction scheme is proposed in Fig. 8, which is in
agreement with several experimental findings. First, in ligation
experiments in the presence of H2O18 an incorporation of O18
into the ligation product could not be observed, indicating that
the acyl-enzymewas notH2O18 hydrolyzed before it was ligated
(14). Second, for the homologous caspases, it has been shown
that the caspase inhibitor p35 binds the enzyme canonically and
thereby displaces the catalytic water. The authors were conse-
quently able to detect a long-lived thioester intermediate in the
electron density (39). Third, for the macrocyclase domain of
PatG, primed residues need to stay bound after forming the
acyl-enzyme intermediate to exclude water from the active site,
albeit achieved by different structural principles (40). Upon
cyclization Pro13(SFTI) cis-trans-isomerization is conforma-
tionally enforced (Fig. S4) (21, 41), resulting in a decreased
affinity and release of the cyclic product (Fig. S4).
Figure 6. S2 pocket of plant legumains has high affinity for hydrophobic P2 residues, critical for water displacement. All structures are results of
330-nsmolecular dynamics simulationswith identical starting structures, despite the indicatedmutation of the primed residues. The different primed tails are
labeled above each structure. Yellow, representation of the still bound product, which is thioester-bound to Cys219 via Asp14; the released primed peptides at
the end of the simulation are also indicated. Cyan, catalytic histidine. Red, Glu220. Dark green, S2 pocket. The putative catalytic water is highlighted. The
individual computed water exclusion times are also shown.
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Daly et al. (41) reported that the P1 Asp14 is hydrogen (and
ionically) bonded to Arg2 in cyclic SFTI, which constraints
Pro13 in the conformation unfavorable for binding. By contrast,
in the D14A SFTI mutant a cis-trans-isomerism of Pro13 (Pro13
switch) was observed. We proposed a similar situation in our
D14N SFTImutant, which should be able to samplemore Pro13
conformations, leading to re-binding to the active site with the
possibility of cyclic SFTI-D14N to be cleaved. This is what we
indeed observed, the cyclic SFTI-D14N was a metastable reac-
tion intermediate toward the stable cleaved product (Fig. S9).
By combination of high resolution crystallographic studieswith
computational and biochemical studies we here provide a both
detailed and integrative mechanism of peptide bond cleavage
and cyclization. The here developed concepts allow to explain
and reconcile many published data and to rationally design
enzymes and substrates with improved properties in proteoly-
sis and ligation.
Experimental procedures
A. thaliana AEP (legumain) isoform  (AtLEG) full-length
clone U10153, locus: AT4G32940, was obtained from TAIR
database. Restriction enzymes and T4 ligase were obtained
from Fermentas (St. Leon-Rot, Germany) and Pfu Ultra II
Fusion HS DNA polymerase was obtained from Stratagene (La
Jolla, CA). Custom-made primers were obtained from Eurofins
Genomics (München, Germany) and sequence analyses were
performed at Eurofins MWGOperon (Martinsried, Germany).
Escherichia coli strain XL2 Blue (Stratagene) was used for sub-
cloning expression constructs. To produce fully glycosylated
protein, the Leishmania tarentolae expression system (LEXSY;
Jena Bioscience, Germany) was used (42). All reagents used
were of the highest standard available from Sigma (München,
Germany) or AppliChem (Darmstadt, Germany).
Cloning
An N-terminal truncated mutant (Ser56–Ala494) of A. thali-
ana proLEG isoform  (referred in this workwith pro-AtLEG)
was amplified by PCR (Eppendorf Mastercycler ep gradient
thermal cycler) to exclude the N-terminal ER-signal peptide
and vacuolar sorting signal (43). A. thaliana legumain isoform
 full-length clone U10153 was used as a template. An appro-
priate forwardprimer containing anXbaI restriction site,His6 tag,
Figure7.Water exclusionmodel of SFTI cyclizationandproteolysis. Top, SFTI-GLbinds canonically (like a substrate) toAtLEG. TheprimedGL tail occupies
the S2 pocket. The N terminus (Gly1) is positioned close to the catalytic cysteine. The attack of the catalytic cysteine creates the acyl-enzyme intermediate,
which can be stabilized by the GL-tail shielding it fromwater. Left, cleavage is achieved when the primed tail of SFTI cannot productively interact with the S2
pocket, which leads to hydrolysis of the thioester, resulting in linear SFTI (L-SFTI). Right, the N terminus of SFTI can attack the thioester and cyclic SFTI (C-SFTI)
is produced. The Pro13 cis-trans-isomerization triggers the efficient off-dissociation. Bottom, the products of the hydrolysis and the cyclization reaction (shown
at the bottom left and bottom right, respectively) are released from enzyme AtLEG (bottom center).
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anda tobaccoetchvirusprotease-cleavage site,AGCTCTCGAG-
TCTAGAGCACCACCATCACCACCACGAAAACCTGTA-
TTTTCAGTCCGGTACTAGGTGGGCTGTTCTAGTC-
GCCG and a reverse primer containing a NotI restriction site,
AGCTGCTCAGCGCGGCCGCCTATGCACTGAATCCAC-
GGTTAAGCGAGCTCCAAGGAC, were used. Subsequently,
the PCR product was cloned into the pLEXSY-sat2 vector uti-
lizing the XbaI and NotI restriction sites. The expression con-
structs carried an N-terminal signal sequence for secretory
expression in the LEXSY supernatant. Correctness of all con-
structs was confirmed by DNA sequencing.
Cell culture, protein expression, and purification
Expression constructs were stably transfected into the
LEXSYP10 host strain and grown at 26 °C in BHImedium (Jena
Bioscience, Germany) supplemented with 5 g/ml of heme in
50 units/ml of penicillin and 50 mg/ml of streptomycin (Carl
Roth GmbH, Germany). Positive clones were selected by addi-
tion of nourseothricin (Jena Bioscience). Protein expression
was carried out as described elsewhere (13). Recombinant pro-
tein was removed from the LEXSY supernatant via Ni2 puri-
fication using nickel-nitrilotriacetic acid Superflow resin (Qia-
gen, Hilden, Germany). The wash buffer contained 20 mM
HEPES, pH 7.2, 300 mM NaCl, and 10% glycerol. The elution
buffer was composed of 20 mM HEPES, pH 7.2, 300 mM NaCl,
10% glycerol, 250 mM imidazole, and 0.3 mM S-methyl meth-
anethiosulfonate. The elution fractions were concentrated
using Amicon Ultra centrifugal filter units (3-kDa molecular
mass cut off, Millipore) and desalted using PD-10 columns (GE
Healthcare) to the final buffer: 20 mM HEPES, pH 7.2, 50 mM
NaCl.
Preparative autoactivation to yield two-chain state and
protease only
2–3mg/ml of pro-AtLEGwere incubated in autoactivation
buffer A (100 mM Tris, 100 mM BisTris, 100 mM citrate, pH 4.0,
100 mMNaCl) for 16 h at 30 °C to generate two-chain AtLEG.
To prepare the protease only, 2–3 mg/ml of pro-AtLEG were
incubated at 30 °C in autoactivation buffer B (100 mM Tris, 100
mM BisTris, 100 mM citrate, pH 4.0, 100 mM NaCl, and 2 mM
DTT) for 2 h. All samples were checked for the presence or
absence of the 6-LSAM domain by SDS-PAGE. After autoac-
tivation, two-chain or protease-only samples were subjected to
gel filtration chromatography utilizing an Äkta-FPLC system
(SEC 200 10/300 GL column, buffer: 20 mM citrate, pH 4.2, 100
mM NaCl) to remove degradation products and DTT. After-
ward, the respective fractions were either used directly for
enzymatic assays or aliquoted and frozen at20 °C.
Protein crystallization
AtLEG was purified as described above. Before concentra-
tion AtLEG was inhibited with Ac-YVAD-CMK at pH 4.0.
After inhibition a SEC runwas performed (SEC 75, 15mM citric
acid, pH 4.5, 80 mM NaCl) and corresponding fractions were
pooled and concentrated to5 mg/ml. Crystallization screen-
ing was carried out using the sitting-drop vapor-diffusion
method utilizing a Hydra II Plus One (Matrix) liquid-handling
system. Crystals grewwithin 3–6 days in a condition consisting
of 4% PEG 4000, 100 mM sodium acetate, pH 4.6.
Data collection and processing
AnX-ray diffraction data set was collected on beamline ID29
at the ESRF at 100 K. The beamline was equipped with a
Pilatus6M detector. Data collection was performed using a
crystal-to-detector distance of 280.919mmand awavelength of
0.976251 Å. The exposure time was 0.04 s at 2.3% transmission.
Data processing was performed by using iMOSFLM (53) and
Aimless from theCCP4program suite (44). Packing densitywas
calculated according to Matthews (45). An initial model could
be generated by molecular replacement with the two-chain
form of AtLEG (PDB code 5NIJ), the structure was refined by
using Refmac 5 (46) and phenix.refine (47). The structure was
deposited with the Protein Data Bank under PDB code 5OBT.
Synthesis and analytics of SFTI-peptides
Materials—Fmoc (N-(9-fluorenyl)methoxycarbonyl)-pro-
tected amino acids, Rink-amide MBHA resin (loading 0.45
mmol/g), H-Asp(OtBu)-2-chlorotrityl-resin (loading 0.60
mmol/g), 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethylu-
ronium hexafluorophosphate (HBTU), N,N-diisopropyleth-
ylamine (DIPEA), piperidine, N,N-dimethylformamide,
N-methyl-2-pyrrolidone, dichloromethane, diethyl ether, ace-
tonitrile, and trifluoroacetic acid were purchased from Merck
Millipore (Germany), Biosolve (The Netherland), and Iris Bio-
tech (Germany). Triisopropylsilane, 1,2-ethanedithiol, thioani-
sole, and N-hydroxybenzotriazole (HOBt) were purchased
from Sigma-Aldrich (Germany). -Cyano-4-hydroxycinnamic
acid was purchased from Acros Organics (Germany).
Methods—Solid-phase peptide synthesis was carried out on
an automatic peptide synthesizer (Syro I, Biotage). The analyt-
ical and semipreparative HPLC equipment was from Thermo
Fisher Scientific (model Ultimate 3000). The analytical column
was from Thermo Fisher Scientific (Syncronis C-18, 4.6 250
mm, 5 m), the semipreparative column was from Macherey
Nagel (NUCLEOSIL C-18, 250  10 mm, 5 m). MALDI-
TOF mass spectra were recorded on an Autoflex mass spec-
Figure 8.Mechanistic scheme of transpeptidation and hydrolysis.Green rectangles show transpeptidation reactions induced by a hydrophobic residue in
P2. The hydrolysis reaction pathway is indicated by cyan rectangles, induced by a nonhydrophobic residue in P2. Starting point: green dashed rectangle. A
substrate (R1 R2) binds to the active site of AtLEG. The attack of Cys219 creates a thioester and free N terminus at the primed site. Left pathway, if the initially
bound substrate (green dashed line) carries a nonhydrophobic residue in P2, the primed product can dissociate after the formation of the thioester andwater
will exchange.Consequently, this results inhydrolysis of the thioester and the releaseof thehydrolysis product.Rightpathway, if P2 is hydrophobic, theprimed
site peptide stays bound and prevents the exchange of catalytic water, resulting in an equilibrium between thioester and peptide bond. In the presence of a
suitable transpeptidation substrate (R3), an exchange between the initially bound primed product and the transpeptidation peptide can happen. This results
in a new equilibrium between thioester and peptide bond, forming the transpeptidation product. The varying protonation state of the released primed N
terminus is indicated. Only a deprotonated N terminus is able to attack the thioester, not a protonated one. This relationship explains the pH dependence of
transpeptidation, which is more efficient at neutral pH than acidic pH.
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trometer from Bruker Daltonics using -cyano-4-hydroxycin-
namic acid as matrix.
Peptide cyclization experiments
Cyclization experiments were performed with 500 M of the
corresponding peptide and 0.5 M AtLEG at 30 °C. The reac-
tion buffer consisted of 100mMMES, pH6.5, and 100mMNaCl.
The ligation mixture was desalted by using the ZipTip Pipette
Tip C-18 (MerckMillipore) and analyzed byMALDI-TOF-MS
(Autoflex, Bruker Daltonics, matrix: -cyano-4-hydroxycin-
namic acid).
Testing peptidase activity
The proteolytic activities of selected activation intermediates
and isoforms were measured using 20 M of the fluorogenic
substrate Z-VAN-MCA or IETD-MCA in activity buffer A
adjusted to the desired pH value (100mMTris, 100mM BisTris,
100 mM citrate, 100 mM NaCl) at 20 °C. For each measured pH
value, the reaction was started by adding around 0.5–2l of the
respective sample to the premixed 49.5 to 48-l mixture. The
concentration of each enzyme in the assay was 1.5 M if not
otherwise stated. The substrate turnover was measured at an
excitation and emission wavelength of 370 and 450 nm, respec-
tively, in an Infinite M200 Plate Reader (Tecan). Proteolytic
activitywas determined by calculation of the initial slopes of the
time-dependent substrate turnover. Each measurement was
done in triplicate.
Structure preparation and docking
Starting from the crystal structure of the fully activat-
ed AtLEG, first the inhibitor was removed from the sys-
tem. Afterward, the enzyme was titrated at pH 6.0 (experi-
mental pH) using the Protonate 3D function of MOE2016.08
(48).
The structure of the substrate, SFTI, was retrieved from the
Protein Database (49): PDB codes 1JBL (cyclic) and 1JBN (non-
cyclic) (21). Because these PDB files comprise several struc-
tures, only one chain was kept and protonated at pH 6.0 as
described above for the enzyme. In case of the noncyclic inhib-
itor (PDB code 1JBN) the C terminus was appended by NME
(N-methyl) to maintain neutrality.
The docking simulationswere performed using the following
settings of the software package ofMOE 2016.08. In the poten-
tial energy setup panel AMBER99 was chosen as force field. As
placement protein–protein docking was employed to find the
optimal docking hits. Each run was adjusted to pre-placement
of 10,000, placement of 500 and refine 30 conformations as a
cut-off. The top poses were retained for further analysis, inves-
tigating the H-bond distances between the substrate and the
enzyme. For AtLEG, residues Cys219, Gly187, His75, Arg74,
Cys252, Cys266, Asp217, Ser247, Asp269, Trp248, Gly249, Glu255,
and Tyr307 were defined as the binding pocket. In addition, as
docking site of the substrate Asp14 was chosen. The best dock-
ing hitswere optimized using the energyminimization function
of MOE2016.08 (48, 50) with AMBER99 force field method.
The docking results were judged by proper interactions
with the S1 pocket and major backbone interactions. In addi-
tion to the well-established computational scoring function,
the interaction-based accuracy classification method (51) was
used to identify the docking hits, which included an interaction
pattern of Asp14(SFTI) in the S1 pocket resembling the exper-
imentally determined geometry (Fig. 1).
Thioester generation and optimization
To generate the tripeptides for the molecular dynamics sim-
ulations, first AtLEGwas superimposedwith the crystal struc-
ture of the human legumain-cystatin (PDB code 4N6O) com-
plex, because in that complex also primed residues are bound.
The P1 to P2 residues were mutated to the sequence of inter-
est and terminated by ACE (acetyl) and NME (N-methyl),
respectively. The so generated complex was optimized using
the energy minimization function of MOE2016.08 (48) with
the AMBER99 force field method. Finally, the peptide bond
between the P1–P1 residues was broken, a covalent bond
between the carbonyl carbon of the P1 aspartic acid and
SG(Cys219) was generated and the complex was reoptimized.
For the molecular dynamics studies the P1 and P2 residues
were systematically mutated using the Protein Builder function
of MOE2016.08 and reoptimized (MOE2016.08, AMBER99
force field).
Molecular dynamics
The protein–peptide complex was solvated in an 80-Å cubic
box of waters and counterions (either Na or Cl) were added
tomaintain neutrality of the overall protein. Afterward, a series
of equilibration stepswere carried out by performingmolecular
dynamics annealing runs for 100 ps at temperatures 50, 150,
200, and 250 K and for 330 ns at 298.15 K (in 11 steps, after each
30 ns the coordinates were saved for further analysis). The
molecular dynamics calculations were accomplished using
AMBER99 force field as implemented into NWChem 6.6 (52).
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